![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/07\/4000-mjna-logo.png\"){kind=logo}
<\/p>\n<\/p>\n
Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway® had its best month ever in Company history in July 2020.<\/p>\n
“Kannaway has made tremendous progress around the world as consumers in Japan and across Asia continue to show an exciting increase in interest for cannabidiol (CBD) products,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Our team has truly shown what can be accomplished with passion, hard work and high-quality products designed to support the body’s crucial endocannabinoid system.”<\/p>\n
According to Prohibition Partners, China and Japan present a large opportunity for Kannaway®’s unique line of CBD products as they collectively account for about 90 percent of Asia’s CBD market, projected to be worth $5.8 billion by 2024.<\/p>\n
“Although Japan is still a new market for us, our record-breaking month in July illustrates that, even amid a global pandemic, consumers in the region are already responding to our hemp-based CBD products with great excitement,” said Kannaway® CEO Blake Schroeder. “I believe we are set up for continued growth and a vibrant future in the market.” <\/p>\n
About Kannaway®<\/p>\n
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.<\/p>\n
About Medical Marijuana, Inc.<\/p>\n
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. <\/p>\n
Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. <\/p>\n
<\/p>\n
CONTACT:<\/p>\n
Public Relations Contact:<\/p>\n
Andrew Hard<\/p>\n
Chief Executive Officer<\/p>\n
CMW Media<\/p>\n
P. 858-264-6600<\/p>\n
andrew.hard@cmwmedia.com<\/p>\n
www.cmwmedia.com<\/p>\n
Investor Relations Contact:<\/p>\n
P. (858) 283-4016<\/p>\n
Investors@medicalmarijuanainc.com<\/p>\n
Tags:<\/b> Andrew Hard
<\/a>, Wire<\/a>, Disclosure Newswire<\/a>, United States<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\nChief Executive Officer
\nCMW Media
\nP. 858-264-6600
\nandrew.hard@cmwmedia.com<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":" Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway® had its best month ever in Company history in July 2020. “Kannaway has made tremendous progress around the world as consumers in Japan … Continue reading Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 2020 as Best Month in Company History for Japanese Division<\/span><\/a> Continue Reading